![]() Resultsįorty-one articles were included (31 DLBCL, 10 HL). Risk of bias was assessed using the Quality in Prognosis Studies (QUIPS) tool. ![]() MethodsĪ search of MEDLINE/PubMed, Web of Science, Cochrane, Scopus and databases was undertaken for articles evaluating PET/CT imaging metrics as outcome predictors in HL and DLBCL. To systematically review the literature evaluating clinical utility of imaging metrics derived from baseline fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) for prediction of progression-free (PFS) and overall survival (OS) in patients with classical Hodgkin lymphoma (HL) and diffuse large B cell lymphoma (DLBCL). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |